<DOC>
	<DOCNO>NCT00734708</DOCNO>
	<brief_summary>This study aim verify effectiveness Trafermin ( recombinant human basic fibroblast growth factor ) stimulate regeneration periodontal tissue lose periodontitis evaluate safety stimulation .</brief_summary>
	<brief_title>Phase 3 Clinical Trial Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 ( Trafermin )</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Alveolar Bone Loss</mesh_term>
	<mesh_term>Periodontal Attachment Loss</mesh_term>
	<criteria>Probing pocket depth 4mm deep Vertical intrabony defect 3 mm deep radiograph baseline Mobility tooth 2 degree less Using investigational drug within past 24 month Coexisting malignant tumour history Coexisting diabetes ( HbA1C 6.5 % ) Taking bisphosphonates Coexisting gingival overgrowth history</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>